BANK OF AMERICA CORP /DE/ - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$119,310
-58.1%
111,505
+1.5%
0.00%
Q2 2023$284,520
-17.0%
109,853
+30.7%
0.00%
Q1 2023$342,867
+25.3%
84,036
+54.2%
0.00%
Q4 2022$273,626
-48.7%
54,507
+33.8%
0.00%
Q3 2022$533,000
-70.5%
40,734
-71.1%
0.00%
Q2 2022$1,806,000
+190.4%
140,882
+245.5%
0.00%
Q1 2022$622,000
-23.6%
40,782
-11.3%
0.00%
Q4 2021$814,000
+17.1%
45,986
+39.2%
0.00%
Q3 2021$695,000
+176.9%
33,025
+159.2%
0.00%
Q2 2021$251,000
+21.3%
12,742
+78.9%
0.00%
Q1 2021$207,000
+8.4%
7,123
+12.6%
0.00%
Q4 2020$191,000
-83.0%
6,326
-91.0%
0.00%
Q3 2020$1,123,000
+308.4%
70,561
+405.7%
0.00%
Q2 2020$275,000
+276.7%
13,953
+136.7%
0.00%
Q1 2020$73,000
-74.9%
5,895
-62.6%
0.00%
Q4 2019$291,000
+977.8%
15,761
+717.1%
0.00%
Q3 2019$27,000
+35.0%
1,929
+44.5%
0.00%
Q2 2019$20,0001,3350.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$237,228,00052.50%
Ponoi II Management, LLC 1,298,908$16,990,00044.41%
Ponoi Management, LLC 1,298,908$16,990,00023.20%
Euclidean Capital LLC 746,674$9,766,0009.07%
StepStone Group LP 1,573,357$20,580,0002.93%
Logos Global Management LP 850,000$11,118,0001.37%
First Light Asset Management, LLC 955,505$12,498,0001.26%
GREAT POINT PARTNERS LLC 316,256$4,137,0001.00%
Rubric Capital Management LP 877,161$11,473,0000.58%
Avidity Partners Management LP 1,798,100$23,519,0000.48%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders